Innovation
26 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 879 times.
| Year | Filings |
|---|---|
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 15 |
| 2024 | 15 |
| 2025 | 10 |
| 2026 | 4 |
Social engagement
Social engagement: 1.2K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Oceanpine Capital, Zheshang Innovation Investment Group, 3E BioVentures, GF Xinde Investment Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 3 | 33% |
| Angel & family office | 1 | 11% |
Recent activity
18 Jun 2026
Event
BIOCHINA Global Forum & Biopharmaceutical Bioprocess Development (BPD) Summit
15 Jun 2026
Product launch
FlipiBody® Platform
3 Jun 2026
Event
World Bispecific & TCE Summit South Korea